Page 6 - Branded Generics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Motilal Oswal has buy call on Ipca Laboratories Ltd. with a target price of Rs 2400. The current market price of Ipca Laboratories Ltd. is Rs 2066.05. Time period given by analyst is one year when Ipca Laboratories Ltd. price can reach defined target. Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 26410.61 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 1134.58 Crore, down -20.39 % from last quarter Total Income of Rs 1425.21 Crore and up 4....

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 167833.48 Crore) operating in Pharmaceuticals sector.

CMP: ₹2,153.75 From our interaction with the management, we believe Ipca Laboratories (IPCA) has enough levers to outperform the market in Domestic Formulations (DF) and Branded Generics exports, with good visibility in the Institutional business and continued momentum in the API segment. IPCA has witnessed sustained growth momentum in the Pain segment. It has posted market share gains, on account of the pandemic, in products wherein smaller companies have been unable to meet supply requirements. Moreover, higher prescriptions for established brands such as Zerodol have enhanced growth pro...

The  Branded Generics Market research report thoroughly explains each and every aspect related to the Global Branded Generics Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. Branded Generics Market Insight: Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026. This rise in market value can be attributed to growin...

Shares of pharmaceutical companies were in focus at the bourses on Wednesday, with the Nifty Pharma surging 4 per cent after a consolidating in the last couple of days. Sun Pharmaceutical Industries and Cipla rallied 6 per cent each, hitting their respective 52-week highs on the National Stock Exchange (NSE) in intra-day trade. Torrent Pharmaceuticals and Dr Reddy’s Laboratories were up 5 per cent, while Divis Laboratories, Lupin, Cadila Healtchare and Biocon from the pharma index were up in the range of 3 per cent to 4 per cent. At 12:57 pm, Nifty Pharma index, the top gainer among sectora...